Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
The Pill Penalty: A Quantified R&D Disincentive The IRAs disparate treatment of small-molecule drugs versus biologics in determining negotiation eligibility timelines is the legislations most consequential and most controversial structural feature
As upregulation of the expression of their receptors has been observed in several human cancers, there is great interest in drugs that might inhibit these lipids by acting as agonists to their receptors
KLOW dosing in research protocol context refers to selecting a reconstitution volume and, if needed, further dilution to achieve the desired per-component concentration for the experimental model
Aug 2012;31(4):448-54
US$ 21.05
US$ 20.75
US$ 29.47
US$ 2990.00
Sold : Login>>